EU May Disclose Some Details Of COVID-19 Vaccine Contracts
Politicians Air Concerns Over Vaccine Hesitancy
Executive Summary
The European Commission seems to be prepared to disclose some parts of the contracts it is signing with companies for coronavirus vaccines, but transparency campaigners say this might not be enough to engender trust in the vaccines among the population at large.
You may also be interested in...
EU ‘Ready To Approve’ COVID-19 Vaccine On 23 December
European parliamentarians have defended the formal marketing authorization approach being taken by the EU, saying “safety is of the utmost importance” if there is to be trust in coronavirus vaccines.
Coronavirus Notebook: Pfizer/BioNTech & Russian Vaccines Each Claim Efficacy Of More than 90%
As data start to come in on the first coronavirus vaccines, hopes are rising that vaccination campaigns will be able to begin in the next month or two, although experts have cautioned against unbridled optimism. Uncertainties also remain over questions such as whom to vaccinate first and how to assure equitable access in less wealthy parts of the world.
Pressure Group Undaunted By EU Refusal To Disclose COVID-19 Vaccine Contracts
The European Commission has dismissed attempts by pressure groups to secure access to details of COVID-19 vaccine deals negotiated with pharmaceutical firms. The Corporate Europe Observatory says it is “disappointed” by the decision but is not giving up the chase.